Sotatercept Endorsed for PAH by ICER
Drug's novel mechanism of action raises hopes of disease-modifying activity, but long-term cost-effectiveness rests on improvement in functional status.
Source: medscape.com
Stay updated with breaking news from Greg Curfman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Drug's novel mechanism of action raises hopes of disease-modifying activity, but long-term cost-effectiveness rests on improvement in functional status.